Gensciences
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- Undisclosed
Investors
- 10
About Gensciences
Founded in 2019 and based in Nantong, China, Gensciences is a biopharmaceutical company that focuses on the research and development of innovative drugs for hemophilia. It currently has 61 patents in the filing and granted, with an R&D team of 150 members. Yali Wang, the chairman of the company, graduated from the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, with 30 years of experience in drug research and development. It has R&D centers in Beijing and Zhengzhou, as well as production bases and marketing branches in Shanghai. In November 2023, it received FDA IND approval for the recombinant factor VIII product. In June 2024, Gensciences closed a strategic investment. Gensciences mainly engages in the research and development of recombinant protein-based innovative drugs and related products. The company set up a bio-innovative drug development system and multiple technology platforms, which can meet the product development of cell culture, microbial fermentation, and other expression systems, covering fusion proteins, protein modification, and other technologies. It currently has 4 innovative drugs that entered clinical development, which are FRSW107, FRSW117, SS109, and SS327. Products can be used in hemophilia, metabolic diseases, and antitumor areas. The company generates revenue by providing recombinant protein-based innovative drugs and related products. In the future, the company will continue to develop bio-innovative drugs in the fields of coagulation and metabolic diseases.
Who invested in Gensciences
10 investors across 2 rounds
See all investors in Gensciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gensciences
Who invested in Gensciences?
Gensciences has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gensciences raised?
Gensciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gensciences last raise money?
Gensciences's most recent round on record is a Series B, in Mar 2021.
What does Gensciences do?
Founded in 2019 and based in Nantong, China, Gensciences is a biopharmaceutical company that focuses on the research and development of innovative drugs for hemophilia.
Where is Gensciences headquartered?
Gensciences is headquartered in Nantong, China.
Which VCs invest in companies like Gensciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Gensciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Gensciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.